Lataa...
The impact of EGFR exon 19 deletion subtypes on clinical outcomes in non-small cell lung cancer
BACKGROUND: The study investigated the resistant pattern and clinical outcomes of epidermal growth factor receptor (EGFR) exon 19 deletion (19del) subtypes to tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC). METHODS: Two hundred eight treatment naive NSCLC patients detected a...
Tallennettuna:
| Julkaisussa: | Transl Lung Cancer Res |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7481579/ https://ncbi.nlm.nih.gov/pubmed/32953493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-19-359 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|